Drug delivery by phospholipase A2 degradable liposomes

Jesper Davidsen, Charlotte Vermehren, Sven Frokjaer, Ole G. Mouritsen, Kent Jørgensen*

*Corresponding author for this work
39 Citations (Scopus)

Abstract

The effect of poly(ethylene glycol)-phospholipid (PE-PEG) lipopolymers on phospholipase A2 (PLA2) hydrolysis of liposomes composed of stearoyl-oleoylphosphatidylcholine (SOPC) was investigated. The PLA2 lag-time, which is inversely related to the enzymatic activity, was determined by fluorescence, and the zeta-potentials of the liposomes were measured as a function of PE-PEG lipopolymer concentration. A significant decrease in the lag-time, and hence an increase in enzymatic activity, was observed with increasing amounts of the negatively charged PE-PEG lipopolymers incorporated into the SOPC liposomes. The enhancement of the PLA2 enzymatic activity might involve a stronger PLA2 binding affinity towards the negatively charged and polymer covered PEG liposomes.

Original languageEnglish
JournalInternational Journal of Pharmaceutics
Volume214
Issue number1-2
Pages (from-to)67-69
Number of pages3
ISSN0378-5173
DOIs
Publication statusPublished - 19 Feb 2001

Keywords

  • Degradation
  • Drug-delivery
  • Lipopolymer
  • Liposomes
  • PEG liposomes
  • Phospholipase A

Fingerprint

Dive into the research topics of 'Drug delivery by phospholipase A2 degradable liposomes'. Together they form a unique fingerprint.

Cite this